ライフサイエンスコーパス: Japanese patient

1 dominantly inherited DRD and in one sporadic Japanese patient.

2 and a severe thrombotic phenotype in a young Japanese patient.

3 as well as American, Canadian, European, and Japanese patients.

4 ata suggest its association with glaucoma in Japanese patients.

5 eported survival benefit observed with IP in Japanese patients.

6 with HTLV-1 that have not been described in Japanese patients.

7 We studied 117 H. pylori-infected Japanese patients.

8 ions (MOCP), we analysed 100 lesions from 26 Japanese patients.

9 y linked to hepatocellular carcinogenesis in Japanese patients.

10 in NEUROG3 are not a common cause of MODY in Japanese patients.

11 nts undergoing hemodialysis than Swedish and Japanese patients.

12 were better in white compared with black and Japanese patients.

13 olangiocarcinomas and gallbladder cancers in Japanese patients.

14 lymorphisms of DLST and AD in both white and Japanese patients.

15 repeat number observed in the C/C homozygous Japanese patients.

16 way, was found to cause this disease in some Japanese patients.

17 patients closely resemble those described in Japanese patients.

18 treatment of genotype 1 hepatitis C virus in Japanese patients.

19 The previous report on the Japanese patients also suggested that disease allele sta

20 in a training set of tissue samples from 82 Japanese patients, and the signature was validated in ti

21 DRD) was originally described in a series of Japanese patients, but is now increasingly recognized in

22 been obtained through studies of Jewish and Japanese patient cohorts carrying founder mutations in t

23 ive and specific for the diagnosis of HCC in Japanese patients compared with alpha-fetoprotein (AFP).

24 We investigated two Japanese patients diagnosed with severe, chronic active

25 Only 0.3% of German and Japanese patients had advance directives, and such direc

26 5 cagA gene-positive H. pylori isolates from Japanese patients including 50 patients with simple gast

27 to the carboxyl terminus of topo I, sera of Japanese patients preferentially recognized the portion

28 roportion of European, African-American, and Japanese patients specifically reacted with the sumoylat

29 A recent report studying Japanese patients suggested that a polymorphism of a tri

30 ion of a novel DNA virus from the serum of a Japanese patient (T.T.) has provided the latest possible

31 i-topo I antibody more frequently in sera of Japanese patients than in sera of white patients.

32 ative for HLA-DQA1*0501 and *0401, including Japanese patients, the HLA-DQA1*0102 and *0103 alleles p

33 cates that the increased sensitivity of some Japanese patients to thiopurines may reflect the greater

34 serum samples from 109 U.S. patients and 288 Japanese patients using enzyme immunoassay with differen

35 Moreover, in another Japanese patient, we identified a homozygous frameshift

36 variants were found within this region in 61 Japanese patients, which could contribute to the pathoge

37 ated in tissue sections taken from 18 US and Japanese patients who died of acute KD and from 10 age-m

38 In this retrospective study, data from 640 Japanese patients who were treated for chronic hepatitis

39 We followed 215 Japanese patients with acute HBV infection until the cle

40 ks in treatment-naive and previously treated Japanese patients with chronic genotype 1 hepatitis C vi

41 es of beta-CAS and alphas-CAS are similar in Japanese patients with CMA.

42 requency of anti-Fibrillin-1 was observed in Japanese patients with diffuse and limited scleroderma o

43 followed by two validation studies, in 3,173 Japanese patients with EGFR mutation-positive lung adeno

44 rvival over etoposide plus cisplatin (EP) in Japanese patients with extensive-stage small-cell lung c

45 as recently detected with high prevalence in Japanese patients with fulminant hepatitis and chronic l

46 ociated with SSc in both Native American and Japanese patients with limited scleroderma.

47 Ninety-six Japanese patients with major depressive disorder were tr

48 16 of the RET proto-oncogene in 33 unrelated Japanese patients with MTC.

49 an unusually high frequency in this group of Japanese patients with myositis.

50 at suggest high risk of the disorder, and 12 Japanese patients with optic-spinal multiple sclerosis.

51 Sera from 36 Japanese patients with PM/DM (13 with PM, 20 with DM, 3

52 ical associations of these autoantibodies in Japanese patients with PM/DM were investigated.

53 of lenalidomide, an oral immunomodulator, in Japanese patients with relapsed adult T-cell leukaemia-l

54 e exome sequencing of 18 trios consisting of Japanese patients with sporadic schizophrenia and their

55 ility to diabetic retinopathy in Chinese and Japanese patients with type 2 diabetes.